Stipend and Dates
Up to $21,600. Multiple payments
Note: All dates and times are tentative and may change | Cohort B4 |
Local patients only - requires proof of local residence (approx. 60-75 miles) with either ID or recent bill. *Be sure your address is correct when scheduling your appointment online. | Patients out of area will be cancelled. |
Day -3 Admit | Jan 15, 2023 |
Day 4 Discharge (a payment within 10 business days after completing visit) | Jan 21, 2023 |
Day 8 Outpatient visit | Jan 25 |
Day 15 Outpatient visit | Feb 01 |
Day 22 Outpatient visit | Feb 08 |
Day 28 Admit | Feb 14, 2023 |
Day 29 Discharge | Feb 15, 2023 |
Day 36 Outpatient visit (a payment within 10 business days after completing visit) | Feb 22 |
Day 43 Outpatient visit | Mar 01 |
Day 50 Outpatient visit | Mar 08 |
Day 56 Admit | Mar 14, 2023 |
Day 57 Discharge | Mar 15, 2023 |
Day 64 Outpatient visit | Mar 22 |
Day 71 Outpatient visit | Mar 29 |
Day 77 Admit | Apr 04, 2023 |
Day 81 Discharge (a payment within 10 business days after completing visit) | Apr 08 , 2023 |
Day 85 Outpatient visit | Apr 12 |
Day 99 Outpatient visit | Apr 26 |
Day 120 Outpatient visit | May 17 |
Day 153 End of Study visit (a payment within 10 business days after completing visit) | Jun 19 |
Click here to make an appointment EL 0219-2190 Part B
Or call 210-225-5437 for more information
Study Criteria
Overweight Males and Females (non-childbearing)
Age: 21-65
BMI: 27-39.9 kg/m2
Study Information
Indication: The investigational drug is being developed as a possible treatment for weight management.
Route of Administration: Subcutaneous (under the skin) injection
Washout from previous study: Have not participated, within the last 30 days or 5 half-lives (whichever is longer), in a clinical study involving an investigational product or are currently participating in a clinical study.
Males who are sexually active and whose partners are females of childbearing potential must agree to remain abstinent or must use condoms throughout the study and for 24 weeks after the last dose of study drug.
Males should not donate sperm throughout the study and for 24 weeks after the last dose of study drug.
Females must not be able to have children (non-childbearing):
- Hysterectomy (removal of uterus), bilateral salpingectomy (removal of both Fallopian tubes), bilateral oophorectomy (removal of both ovaries)
- Post-Menopausal more than one year prior to study entry (stopped having monthly menstrual periods more than one year ago)
Study Reminders
- 8 hours fasting is required for lab work (only water is allowed)
- If taking medications, bring them to your screening appointment (including prescription, over the counter, herbal supplements and vitamins)
- Bring a valid, non-expired photo ID with you when you attend your screening visit. We accept a valid government issued identification card such as a driver's license, state issued ID card or passport. You will be required to show this same photo ID at all study visits
- Arrive 30 minutes before your appointment to complete paper work.
- Reference
- EL 0219-2190 Part B
- Name
- Healthy Overweight Males and Non-Childbearing Females
- Details
- Local Patients Only - Proof of address required. Not Currently Screening.
- Gender
- Male or Female
- Payment amount
- Up to $21,600
- Age
- 21 - 65
- Smoking
- Non-smokers